MedsPaL provides information on the patent and licensing status of selected HIV, hepatitis C, tuberculosis and other patented essential medicines in low- and middle-income countries. For more detailed and up-to-date information on a given patent application, MedsPaL users are encouraged to contact the national patent office or consult legal counsel.

MedsPaL now includes some of the patented medicines being tested for the treatment of COVID-19
Select a product to display related patent or licence information per country directly on the map.
Share This Search

Highlight countries